London-based Inflexion has held a £2.3 billion (around $3.1 billion) final close of its first-ever multi-asset continuation fund—the largest vehicle of its kind raised in Europe to date.
Inflexion Continuation Fund I, which is underwritten by lead investors AlpInvest Partners, HarbourVest Partners and Lexington Partners, injects new capital into four UK portfolio companies so they can acquire new businesses.
The companies include condensate pump maker Aspen Pumps, which Inflexion bought from 3i Group at a £400 million valuation in 2020, and liquid pharmaceutical business Rosemont Pharmaceuticals, which Inflexion bought it through a £156M LBO in 2020..
The other two portfolio companies are fund administrator Ocorian, which Inflexion has held for nine years, and specialty pharmaceutical platform CNX Therapeutics, which it bought in 2021.
Europe saw a record-breaking 23 continuation vehicles close last year. Eight continuation vehicles have closed so far this year, including the Inflexion fund.
Nicolas Moura, a PitchBook senior EMEA private capital analyst, expects continuation vehicles to continue growing regardless of the exit market.
“We’ve seen GP-led secondary exit value more than double over the past five years while exit counts have risen by even more, according to our Q4 2024 PitchBook Analyst Note: GP-Led Secondaries. We expect continuation vehicles to continue growing their share of the exit market, even if the exit market stabilizes and returns to growth, because it allows the GP to hold on to their trophy assets whilst offering a liquidity event for LPs.”
However, getting into the market can be challenging. In February, Secondaries Investor reported that UK firm Astorg has decided to withdraw from the secondaries market, citing difficulty in entering the new segment.
This latest vehicle generated Inflexion’s investors net proceeds of £1.5 billion, realizing a 3.4x return, according to Inflexion. However, the continuation fund generated a lower IRR at 28%, where Inflexion saw a 33% IRR across its 71 exits since the firm’s inception.
Featured image by Hello World/Getty Images
Learn about our editorial standards.